Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 393)
Posted On: 04/09/2019 1:47:09 PM
Post# of 154678
Posted By: misiu143
FDA approves.... "Dovato" .....Dolutegravil /Lamivudine for treatment -naive patients ....

" 2 drugs regimen in a single tabl ,while eliminating additional toxicity and potential drug interactions from a third drug "

and for patients with no resistance to this drugs ,....

-2% of patients withdrew from study because of serious side effects ,

- severe hypersensitivity may happen ,
including organ dysfunction and liver injury have been reported with Dolutegravil .
Discontinue DOVATO immediately if any sign or symptoms .

-Lactic acidosis and severe hepatomegaly with steatosis , including fatal cases have been reported with nucleoside analogues ..

-contraindicated with patient with kidney or liver impairment ..

- drug interaction may happen , check with your physician..

-Human Reconstitution Syndrome , has been reported ( autoimmune reaction )

-and in addition to other less severe side effects , patients may develop resistant Hepatitis B , so...

-The labeling includes a Boxed Warning that patients with Hepatitis B may develop resistant Hepatitis B and liver toxicities , including liver failure ..






















(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site